Wells David R. Insider Trades

Insider Trading History

Track insider trading activity for Wells David R.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Heart Test Laboratories
Heart Test Laboratories HSCS
Director
Holding Value $30.2k 15,000 shares
Last Trade
Jan 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$47.6k 15,000 shares
$3.17
$2.01
Heart Test Laboratories - Warrants(15/06/2027)
Heart Test Laboratories - Warrants(15/06/2027) HSCSW
Director
Holding Value $753 15,000 shares
Last Trade
Jan 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.35k 15,000 shares
$0.09
$0.05
Heart Test Laboratories - Warrants(15/06/2027)
Heart Test Laboratories - Warrants(15/06/2027) HSCSW
Director
Holding Value $1.26k 25,000 shares
Last Trade
Jul 09, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.48k 25,000 shares
$0.10
$0.05
Heart Test Laboratories
Heart Test Laboratories HSCS
Director
Holding Value $50.3k 25,000 shares
Last Trade
Jul 09, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$109k 25,000 shares
$4.37
$2.01
Heart Test Laboratories
Heart Test Laboratories HSCS
Director
Holding Value $12.1k 6,000 shares
Last Trade
Jan 16, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20k 6,000 shares
$3.33
$2.01
Heart Test Laboratories - Warrants(15/06/2027)
Heart Test Laboratories - Warrants(15/06/2027) HSCSW
Director
Holding Value $301 6,000 shares
Last Trade
Jan 16, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$268 6,000 shares
$0.04
$0.05
Anzu Special Acquisition I
Anzu Special Acquisition I ANZU
Chief Financial Officer
Holding Value $2.01M 293,250 shares
Last Trade
Oct 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.06M 293,250 shares
$7.02
$6.86
Anzu Special Acquisition I - Warrants (27/01/2026)
Anzu Special Acquisition I - Warrants (27/01/2026) ANZUW
Chief Financial Officer
Holding Value $24.9k 293,250 shares
Last Trade
Oct 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.1k 293,250 shares
$0.09
$0.08
Anzu Special Acquisition I - Units (1 Ord Class A & 1/3 War)
Anzu Special Acquisition I - Units (1 Ord Class A & 1/3 War) ANZUU
Chief Financial Officer
Holding Value $2.08M 293,250 shares
Last Trade
Oct 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.08M 293,250 shares
$7.09
$7.09
Envoy Medical
Envoy Medical COCH
Chief Financial Officer
Holding Value $206k 293,250 shares
Last Trade
Oct 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$704k 293,250 shares
$2.40
$0.70
Envoy Medical- Warrants (29/09/2028)
Envoy Medical- Warrants (29/09/2028) COCHW
Chief Financial Officer
Holding Value $18.2k 293,250 shares
Last Trade
Oct 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.2k 293,250 shares
$0.05
$0.06
Heart Test Laboratories - Warrants(15/06/2027)
Heart Test Laboratories - Warrants(15/06/2027) HSCSW
Director
Holding Value $2.51k 50,000 shares
Last Trade
Mar 20, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$300k 50,000 shares
$6.00
$0.05
ENDRA Life Sciences
ENDRA Life Sciences NDRA
Chief Financial Officer
Holding Value $119k 25,000 shares
Last Trade
Apr 05, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.31B 25,000 shares
$92,400.00
$4.77
ENDRA Life Sciences- Warrants (12/05/2022)
ENDRA Life Sciences- Warrants (12/05/2022) NDRAW
Chief Financial Officer
Holding Value $750 25,000 shares
Last Trade
Apr 05, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.8k 25,000 shares
$0.75
$0.03
ENDRA Life Sciences
ENDRA Life Sciences NDRA
Chief Financial Officer
Holding Value $382k 80,003 shares
Last Trade
Jan 06, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.03B 34,900 shares
$29,424.50
$4.77
ENDRA Life Sciences- Warrants (12/05/2022)
ENDRA Life Sciences- Warrants (12/05/2022) NDRAW
Chief Financial Officer
Holding Value $2.4k 80,003 shares
Last Trade
Jan 06, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.59k 34,900 shares
$0.16
$0.03
ENDRA Life Sciences
ENDRA Life Sciences NDRA
Chief Financial Officer
Holding Value $548k 114,903 shares
Last Trade
Jan 05, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.12M 100 shares
$31,150.00
$4.77
ENDRA Life Sciences- Warrants (12/05/2022)
ENDRA Life Sciences- Warrants (12/05/2022) NDRAW
Chief Financial Officer
Holding Value $3.45k 114,903 shares
Last Trade
Jan 05, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$19.5 100 shares
$0.19
$0.03
ENDRA Life Sciences- Warrants (12/05/2022)
ENDRA Life Sciences- Warrants (12/05/2022) NDRAW
Chief Financial Officer
Holding Value $152 5,051 shares
Last Trade
Jun 23, 2020 Sale (In The Money)Reported as In The Money on SEC Form 4.
$900 5,000 shares
$0.18
$0.03
ENDRA Life Sciences- Warrants (12/05/2022)
ENDRA Life Sciences- Warrants (12/05/2022) NDRAW
Chief Financial Officer
Holding Value $3.45k 115,003 shares
Last Trade
Jun 23, 2020 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$900 5,000 shares
$0.18
$0.03

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up